Summary
Skin neoplasms are common concerns for which patients seek medical attention. Familiarity with these benign and malignant tumors is essential for appropriate evaluation and management. In the current era, skin cancer is the most common neoplasm in humans—more than 1 million new cases will be diagnosed in the United States this year. Pigmented lesions pose a particular challenge because melanoma, the potentially lethal form of skin cancer, is always part of the differential diagnosis. Fortunately, early detection and prompt treatment of skin cancer, especially in the case of melanoma, improve overall prognosis and survival.
This chapter reviews the epidemiology, pathogenesis, clinical presentation, histopa-thology, and management of common benign and malignant skin tumors including sebor-rheic keratoses, melanocytic nevi, actinic keratoses, squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and melanoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AJCC:
-
American Joint Committee on Cancer
- BCC:
-
Basal cell carcinoma
- DFSP:
-
Dermatofibrosarcoma protuberans
- EMPD:
-
Extramammary Paget's disease
- FAMMM:
-
Familial atypical multiple mole melanoma syndrome
- MAC:
-
Microcystic adnexal carcinoma
- NMSC:
-
Nonmelanoma skin cancer
- PUVA:
-
Psoralen plus ultraviolet A radiation
- SLNB:
-
Sentinel lymph node biopsy
- SCC:
-
Squamous cell carcinoma
References
Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292:2771–2776.
Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344:975–983.
American Academy of Dermatology, Be Sun Smartsm. Available at http://www.aad.org/public/sun/smart.html. Accessed December 13, 2007.
American Cancer Society, Cancer Facts and Figures. Available at http://www.cancer.org/docroot/STT/con-tent/STT_1x_Cancer_Facts__Figures_2007.asp. Accessed December 13, 2007.
Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8–18.
Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2007;120:26e–40e.
Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–3648.
Benjamin CL, Ananthaswamy HN. p53 and the pathogen-esis of skin cancer. Toxicol Appl Pharmacol. 2007;224:241–248.
Benvenuto-Andrade C, Oseitutu A, Agero AL, Marghoob AA. Cutaneous melanoma: surveillance of patients for recurrence and new primary melanomas. Dermatol Ther. 2005;18:423–435.
Black HS, Thornby JI, Wolf JE, Jr et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. Int J Cancer. 1995;62:165–169.
Bub JL, Berg D, Slee A, Odland PB. Management of len-tigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol. 2004;140:552–558.
Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28:268–273.
Clark WH Jr, Elder DE, Guerry D 4th, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147–1165.
De Hertog SA, Wensveen CA, et al. Leiden Skin Cancer Study Relation between smoking and skin cancer. J Clin Oncol. 2001;19:231–238.
Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for actinic keratoses. Committee on guidelines of care. J Am Acad Dermatol. 1995;32:95–98.
Garcia C, Holman J, Poletti E. Mohs surgery: commentaries and controversies. Int J Dermatol. 2005;44:893–905.
Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000–2006) and future directions. J Am Acad Dermatol. 2007;57:555–572.
Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. Clin Oncol. 1999;17:976–983.
Grob JJ, Bonerandi JJ. The ‘ugly duckling’ sign: identifi-cation of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134:103–104.
Grossman L. Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ Health Perspect. 1997;105:927–930.
Hafner C, Hartmann A, Real FX, Hofstaedter F, Landthaler M, Vogt T. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol. 2007;127:1883–1885.
Huilgol SC, Selva D, Chen C, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol. 2004;140:1087–1092.
International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer. 2007;120:1116–1122.
Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst. 2002;94:224–226.
Krengel S, Hauschild A, Schäfer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006;155:1–8.
Kwon OS, Hwang EJ, Bae JH, et al. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed. 2003;19:73–80.
Lang PG Jr. The role of Mohs' micrographic surgery in the management of skin cancer and a perspective on the management of the surgical defect. Clin Plast Surg. 2004;31:5–31.
Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53:253–260.
Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol. 2005;53:452–457.
Lim C. Seborrhoeic keratoses with associated lesions: a retrospective analysis of 85 lesions. Australas J Dermatol. 2006;47:109–113.
Marcil I, Stern RS. Risk of developing a subsequent non-melanoma skin cancer in patients with a history of non-melanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136:1524–1530.
Markovic SN, Erickson LA, Rao RD, et al. Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82:364–380.
Markovic SN, Erickson LA, Rao RD, et al. Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82:490–513.
McIntyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratoses. Am Fam Physician. 2007;76:667–671.
Naeyaert JM, Brochez L. Dysplastic nevi. N Engl J Med. 2003;349:2233–2240.
National Comprehensive Cancer Network, NCNN. Clinical Practice Guidelines in Oncolgy, Melanoma. Available at http://www.nccn.org/professionals/physi-cian_gls/PDF/melanoma.pdf. Accessed December 19, 2007.
Neville JA, Welch E, Leffell DJ. Management of nonmela-noma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4:462–469.
Ridky TW. Nonmelanoma skin cancer. J Am Acad Dermatol. 2007;57:484–501.
Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol. 2007;46:895–904.
Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353:2262–2269.
Santibanez-Gallerani A, Marshall D, Duarte AM, Melnick SJ, Thaller S. Should nevus sebaceus of Jadassohn in children be excised? A study of 757 cases, and literature review. J Craniofac Surg. 2003;14:658–660.
Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39:79–97.
Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol. 1992;18:471–476.
Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg. 2004;23:145–157.
Thomas CJ, Wood GC, Marks VJ. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience. Dermatol Surg. 2007; 33:333–339.
Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351:998–1012.
Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg. 2007;33:885–899.
Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol. 1997;137:411–414.
Yu RC, Pryce DW, Macfarlane AW, Stewart T W. A histo-pathological study of 643 cutaneous horns. Br J Dermatol. 1991;124:449–452.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Djohan, R.S., Tung, R., Fernandez-Faith, E., Karai, L. (2010). Benign and Malignant Skin Tumors. In: Siemionow, M.Z., Eisenmann-Klein, M. (eds) Plastic and Reconstructive Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84882-513-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-84882-513-0_16
Publisher Name: Springer, London
Print ISBN: 978-1-84882-512-3
Online ISBN: 978-1-84882-513-0
eBook Packages: MedicineMedicine (R0)